77.62
price up icon2.27%   1.72
after-market Handel nachbörslich: 77.61 -0.01 -0.01%
loading
Schlusskurs vom Vortag:
$75.90
Offen:
$74.91
24-Stunden-Volumen:
530.73K
Relative Volume:
0.61
Marktkapitalisierung:
$12.31B
Einnahmen:
$1.16B
Nettoeinkommen (Verlust:
$168.11M
KGV:
51.07
EPS:
1.52
Netto-Cashflow:
$236.10M
1W Leistung:
+9.73%
1M Leistung:
+3.80%
6M Leistung:
+0.43%
1J Leistung:
+32.19%
1-Tages-Spanne:
Value
$73.92
$77.65
1-Wochen-Bereich:
Value
$73.75
$79.46
52-Wochen-Spanne:
Value
$55.63
$85.57

Bio Techne Corp Stock (TECH) Company Profile

Name
Firmenname
Bio Techne Corp
Name
Telefon
(612) 379-8854
Name
Adresse
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Name
Mitarbeiter
3,100
Name
Twitter
@biotechne
Name
Nächster Verdiensttermin
2024-10-30
Name
Neueste SEC-Einreichungen
Name
TECH's Discussions on Twitter

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-05-22 Herabstufung Citigroup Buy → Neutral
2024-02-08 Eingeleitet Scotiabank Sector Outperform
2024-02-02 Herabstufung Stifel Buy → Hold
2023-12-07 Eingeleitet UBS Buy
2023-08-28 Eingeleitet William Blair Outperform
2023-01-10 Hochstufung Wells Fargo Underweight → Equal Weight
2022-12-14 Eingeleitet Deutsche Bank Buy
2022-12-12 Hochstufung Citigroup Neutral → Buy
2022-12-07 Eingeleitet RBC Capital Mkts Sector Perform
2022-08-25 Eingeleitet Credit Suisse Outperform
2022-04-25 Herabstufung Wells Fargo Equal Weight → Underweight
2021-09-15 Hochstufung KeyBanc Capital Markets Sector Weight → Overweight
2021-03-08 Hochstufung Stephens Equal-Weight → Overweight
2021-02-23 Hochstufung Stifel Hold → Buy
2021-01-25 Bestätigt The Benchmark Company Buy
2020-11-10 Eingeleitet KeyBanc Capital Markets Sector Weight
2020-09-30 Eingeleitet Atlantic Equities Overweight
2020-07-15 Herabstufung Stephens Overweight → Equal-Weight
2020-05-27 Herabstufung Stifel Buy → Hold
2020-05-14 Eingeleitet The Benchmark Company Buy
2020-01-08 Fortgesetzt Stephens Overweight
2020-01-08 Eingeleitet Wells Fargo Equal Weight
2020-01-07 Eingeleitet Citigroup Neutral
2019-11-15 Eingeleitet Stifel Buy
2019-07-02 Hochstufung Janney Neutral → Buy
2019-01-14 Hochstufung Stephens Equal-Weight → Overweight
2018-10-31 Herabstufung Craig Hallum Buy → Hold
2018-10-17 Eingeleitet Goldman Neutral
2018-06-15 Eingeleitet Argus Buy
2017-07-13 Eingeleitet Wells Fargo Market Perform
2017-02-09 Eingeleitet Citigroup Buy
2017-01-18 Eingeleitet Deutsche Bank Buy
2016-11-10 Fortgesetzt Leerink Partners Outperform
2015-01-21 Bestätigt Robert W. Baird Outperform
2013-09-20 Hochstufung Robert W. Baird Neutral → Outperform
Alle ansehen

Bio Techne Corp Aktie (TECH) Neueste Nachrichten

pulisher
05:25 AM

Bio-Techne awards CFO restricted stock units for retention - Investing.com

05:25 AM
pulisher
07:00 AM

LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH - Yahoo Finance

07:00 AM
pulisher
04:49 AM

Bio-Techne Co. (NASDAQ:TECH) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

04:49 AM
pulisher
Nov 04, 2024

Bio-Techne Tops Q1 Earnings & Revenue Estimates, Stock Up in Premarket - MSN

Nov 04, 2024
pulisher
Nov 04, 2024

Bio-Techne Corp (TECH)'s Winning Formula: Financial Metrics and Competitive Strengths - GuruFocus.com

Nov 04, 2024
pulisher
Nov 03, 2024

New York State Common Retirement Fund Reduces Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 03, 2024
pulisher
Nov 03, 2024

Bio-Techne (NASDAQ:TECH) Raised to Buy at StockNews.com - Defense World

Nov 03, 2024
pulisher
Nov 02, 2024

Bio-Techne (NASDAQ:TECH) Upgraded to Buy at StockNews.com - MarketBeat

Nov 02, 2024
pulisher
Nov 01, 2024

9 Best Biotech Stocks Of November 2024 - Forbes

Nov 01, 2024
pulisher
Nov 01, 2024

Bio-Techne Corporation (NASDAQ:TECH) Q1 2025 Earnings Call Transcript - Insider Monkey

Nov 01, 2024
pulisher
Oct 31, 2024

TECH (Bio-Techne) Total Inventories : $185 Mil (As of Sep. 2024) - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

Bio-Techne shares target raised, outperform on strong Q1 results By Investing.com - Investing.com Australia

Oct 31, 2024
pulisher
Oct 31, 2024

Earnings call: Bio-Techne reports steady growth in Q1 FY2025 - Investing.com

Oct 31, 2024
pulisher
Oct 31, 2024

Earnings call: Bio-Techne reports steady growth in Q1 FY2025 By Investing.com - Investing.com UK

Oct 31, 2024
pulisher
Oct 31, 2024

Bio-Techne shares target raised, outperform on strong Q1 results - Investing.com India

Oct 31, 2024
pulisher
Oct 31, 2024

Robert W. Baird Forecasts Strong Price Appreciation for Bio-Techne (NASDAQ:TECH) Stock - MarketBeat

Oct 31, 2024
pulisher
Oct 31, 2024

Bio-Techne Corp (TECH) Q1 2025 Earnings Call Highlights: Navigat - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

Bio-Techne Corp (TECH) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges in a ... - Yahoo Finance

Oct 31, 2024
pulisher
Oct 30, 2024

Bio-Techne holds at $80 target with Overweight rating - Investing.com India

Oct 30, 2024
pulisher
Oct 30, 2024

Bio-Techne holds at $80 target with Overweight rating By Investing.com - Investing.com South Africa

Oct 30, 2024
pulisher
Oct 30, 2024

Objective long/short (TECH) Report - Stock Traders Daily

Oct 30, 2024
pulisher
Oct 30, 2024

Bio-Techne Tops Profit Forecasts Thanks To Booming Diagnostics - Finimize

Oct 30, 2024
pulisher
Oct 30, 2024

Bio-Techne Q1 25 Earnings Conference Call At 9:00 AM ET - Nasdaq

Oct 30, 2024
pulisher
Oct 30, 2024

Bio-Techne beats quarterly profit estimates, driven by diagnostic unit growth; shares rise - Reuters

Oct 30, 2024
pulisher
Oct 30, 2024

Bio-Techne Corp (TECH) Q1 FY2025 Earnings: Revenue Surpasses Est - GuruFocus.com

Oct 30, 2024
pulisher
Oct 30, 2024

Bio-Techne earnings beat by $0.04, revenue topped estimates - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS - Yahoo Finance

Oct 30, 2024
pulisher
Oct 30, 2024

Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Creative Planning - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

Sequoia Financial Advisors LLC Purchases Shares of 2,725 Bio-Techne Co. (NASDAQ:TECH) - Defense World

Oct 30, 2024
pulisher
Oct 29, 2024

Global Exosome Market to Surge at a Tremendous CAGR of ~20% by 2030 | DelveInsight - GlobeNewswire Inc.

Oct 29, 2024
pulisher
Oct 29, 2024

ScaleReady Announces a G-Rex® Grant has been awarded to Luminary Therapeutics - Yahoo Finance

Oct 29, 2024
pulisher
Oct 28, 2024

Director Keegan Joseph D was granted 1,462 shares, increasing direct ownership by 12% to 13,771 units (SEC Form 4) - Quantisnow

Oct 28, 2024
pulisher
Oct 28, 2024

IFM Investors Pty Ltd Boosts Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Oct 28, 2024
pulisher
Oct 26, 2024

Bio-Techne Gears Up for Q1 Earnings Release: What's in the Cards? - MSN

Oct 26, 2024
pulisher
Oct 25, 2024

Hahn Capital Management LLC Reduces Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Oct 25, 2024
pulisher
Oct 24, 2024

Raymond James & Associates Boosts Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Oct 24, 2024
pulisher
Oct 23, 2024

Bio-Techne, Ex-Lead Scientist Settle Religious Bias Claim (1) - Bloomberg Law

Oct 23, 2024
pulisher
Oct 23, 2024

Bio-Techne (TECH) Scheduled to Post Earnings on Wednesday - MarketBeat

Oct 23, 2024
pulisher
Oct 22, 2024

Allspring Global Investments Holdings LLC Decreases Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Oct 22, 2024
pulisher
Oct 21, 2024

CRISPR-based Gene Editing Market Report 2024-2030, Featuring Revvity, Danaher, GenScript, Merck, Tocris Bioscience, OriGene Technologies, Bio-Rad Laboratories, Bio-Techne & New England Biolabs - Yahoo Finance

Oct 21, 2024
pulisher
Oct 21, 2024

S&P 500 Futures Fall in Premarket Trading; Kenvue, Bio-Techne Lead - Barron's

Oct 21, 2024
pulisher
Oct 19, 2024

When the Price of (TECH) Talks, People Listen - Stock Traders Daily

Oct 19, 2024
pulisher
Oct 16, 2024

What You Need To Know Ahead Of Bio-Techne's Earnings Release - Barchart

Oct 16, 2024
pulisher
Oct 16, 2024

What You Need to Know Ahead of Bio-Techne's Earnings Release - Inkl

Oct 16, 2024
pulisher
Oct 16, 2024

Sanctuary Advisors LLC Takes Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

Transferrin Monoclonal Antibody Market 2034 Insights with Key Innovations Analysis |MyBiosource, Inc., Bio-Techne, ​​Abc – IndiaPolitics.com - IndiaPolitics.com

Oct 15, 2024
pulisher
Oct 14, 2024

Anti-Olig2 Antibody Market Year 2034|Sino Biological, Inc., Boster Biological Technology, Bio-Techne, Thermo Fisher, CLO – IndiaPolitics.com - IndiaPolitics.com

Oct 14, 2024
pulisher
Oct 14, 2024

CD30 (TNFRSF8) ELISA Kit Market Growth Report |Sino Biological, Inc., Bio-Techne, MyBiosource, Inc., Boster Biological T – IndiaPolitics.com - IndiaPolitics.com

Oct 14, 2024
pulisher
Oct 14, 2024

An Analysis of Bio-Techne Corp (TECH)’s Potential Price Growth - Knox Daily

Oct 14, 2024
pulisher
Oct 14, 2024

Investors in cash trouble should check out Bio-Techne Corp (TECH) - SETE News

Oct 14, 2024
pulisher
Oct 11, 2024

Bio-Techne Co. (NASDAQ:TECH) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Oct 11, 2024

Finanzdaten der Bio Techne Corp-Aktie (TECH)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Bio Techne Corp-Aktie (TECH) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Kelderman Kim
Chief Executive Officer
Aug 29 '24
Option Exercise
66.97
1,492
99,919
41,434
Bohnen Shane
SVP - General Counsel
Aug 15 '24
Option Exercise
0.00
49
0
1,696
BAUMGARTNER ROBERT V
Director
Aug 08 '24
Option Exercise
22.95
16,000
367,200
59,401
BAUMGARTNER ROBERT V
Director
Aug 08 '24
Sale
72.10
16,000
1,153,664
43,401
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):